BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2468325)

  • 1. Virus strain specificity of challenge immunity to coronavirus.
    Barthold SW; Smith AL
    Arch Virol; 1989; 104(3-4):187-96. PubMed ID: 2468325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of challenge immunity to coronavirus JHM in mice.
    Barthold SW; Smith AL
    Arch Virol; 1989; 107(3-4):171-7. PubMed ID: 2554852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration and strain-specificity of immunity to enterotropic mouse hepatitis virus.
    Homberger FR; Barthold SW; Smith AL
    Lab Anim Sci; 1992 Aug; 42(4):347-51. PubMed ID: 1331605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of mice to murine coronavirus immunization.
    Smith AL; de Souza MS; Finzi D; Barthold SW
    Arch Virol; 1992; 125(1-4):39-52. PubMed ID: 1322658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of mice susceptible or resistant to lethal infection with mouse hepatitis virus, strain JHM, after exposure by a natural route.
    Garlinghouse LE; Smith AL
    Lab Anim Sci; 1985 Oct; 35(5):469-72. PubMed ID: 2414512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse hepatitis virus and host determinants of vertical transmission and maternally-derived passive immunity in mice.
    Barthold SW; Beck DS; Smith AL
    Arch Virol; 1988; 100(3-4):171-83. PubMed ID: 2840871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope.
    Koo M; Bendahmane M; Lettieri GA; Paoletti AD; Lane TE; Fitchen JH; Buchmeier MJ; Beachy RN
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7774-9. PubMed ID: 10393897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis virus JHM.
    Barthold SW; Smith AL
    Virus Res; 1987 May; 7(3):225-39. PubMed ID: 3037819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivities of 4 murine coronavirus antigens with immunized or naturally infected rat sera by enzyme linked immunosorbent assay.
    Machii K; Iwai H; Otsuka Y; Ueda K; Hirano N
    Jikken Dobutsu; 1988 Jul; 37(3):251-5. PubMed ID: 2843391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species.
    Barthold SW; de Souza MS; Smith AL
    Lab Anim Sci; 1990 Sep; 40(5):481-5. PubMed ID: 2170746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody.
    Perlman S; Schelper R; Bolger E; Ries D
    Microb Pathog; 1987 Mar; 2(3):185-94. PubMed ID: 2853274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype.
    Barthold SW; Beck DS; Smith AL
    Arch Virol; 1986; 91(3-4):247-56. PubMed ID: 3022679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
    J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal challenge immunity of mice to antigenically homologous and heterologous strains of mouse hepatitis virus.
    Barthold SW; Beck DS
    Adv Exp Med Biol; 1987; 218():449-50. PubMed ID: 2829558
    [No Abstract]   [Full Text] [Related]  

  • 15. Epitope-specific antibody response to murine hepatitis virus-4 (strain JHM).
    Talbot PJ; Salmi AA; Knobler RL; Buchmeier MJ
    J Immunol; 1985 Feb; 134(2):1217-24. PubMed ID: 2578156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of mouse hepatitis virus infection: studies in immunocompetent and chemically immunosuppressed mice.
    Barthold SW; Smith AL
    Lab Anim Sci; 1990 Mar; 40(2):133-7. PubMed ID: 2157090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasally administered alpha/beta interferon prevents extension of mouse hepatitis virus, strain JHM, into the brains of BALB/cByJ mice.
    Smith AL; Barthold SW; Beck DS
    Antiviral Res; 1987 Dec; 8(5-6):239-45. PubMed ID: 2837142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passively acquired challenge immunity to enterotropic coronavirus in mice.
    Homberger FR; Barthold SW
    Arch Virol; 1992; 126(1-4):35-43. PubMed ID: 1326267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus-induced encephalomyelitis: balance between protection and immune pathology depends on the immunization schedule with spike protein S.
    Flory E; Stühler A; Barac-Latas V; Lassmann H; Wege H
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():873-9. PubMed ID: 9049333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection.
    Wesseling JG; Godeke GJ; Schijns VE; Prevec L; Graham FL; Horzinek MC; Rottier PJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2061-9. PubMed ID: 8409930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.